Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) Asset Utilization Ratio (2020 - 2025)

Historic Asset Utilization Ratio for Fennec Pharmaceuticals (FENC) over the last 6 years, with Q3 2025 value amounting to 0.82.

  • Fennec Pharmaceuticals' Asset Utilization Ratio rose 193.93% to 0.82 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.82, marking a year-over-year increase of 193.93%. This contributed to the annual value of 1.32 for FY2024, which is 6759.56% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported Asset Utilization Ratio of 0.82 as of Q3 2025, which was up 193.93% from 0.73 recorded in Q2 2025.
  • Fennec Pharmaceuticals' 5-year Asset Utilization Ratio high stood at 0.94 for Q1 2024, and its period low was 0.04 during Q4 2022.
  • Its 5-year average for Asset Utilization Ratio is 0.4, with a median of 0.37 in 2023.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first crashed by 35013.4% in 2022, then skyrocketed by 438041.21% in 2023.
  • Fennec Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.01 in 2021, then plummeted by 896.63% to 0.04 in 2022, then skyrocketed by 2366.74% to 0.91 in 2023, then grew by 0.88% to 0.92 in 2024, then decreased by 9.97% to 0.82 in 2025.
  • Its last three reported values are 0.82 in Q3 2025, 0.73 for Q2 2025, and 0.68 during Q1 2025.